coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Preston Park Community PCN, Brighton and Hove (LAD) · Health Inequalities Profile

    PCN U09072 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    54,360

    Registered population

    67.3% aged 18–64

    15.9%

    Aged 65+

    ICB 21.9% · England 17.9%

    14.4%

    Ethnic minority (non-White)

    4.7% Asian · England 9.6%

    7.8%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~3,732

    Core20 residents (est.)

    Resident basis; registered basis ~3,829 · see page 3

    6,358

    Hypertension register

    +8.03% in 3 yrs · England +5.60%

    588

    SMI register

    12.7% of Brighton and Hove (LAD)'s

    682

    COPD register

    Reviews +1.06% in 3 yrs

    Forecast to 2030

    7,528

    Hypertension patients, 2030

    +1,170 on today

    60.1%

    QRISK ≥20% on statins, 2030

    +1.66pp over 3 yrs

    4.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.0%
    Asthma review coverage trails England and fell.

    Coverage is 56.0% versus 65.7% in England (fell 2.9% vs +4.4%), leaving about 1,400 of 3,259 registered patients unreviewed, which may reflect recall gaps.

    59.1%
    High-risk lipid therapy trails England at higher cost.

    Lipid therapy in CKD is 59.1% (England 70.3%) and QRISK ≥ 20% is 56.6% (63.6%), while item cost is £2.70 versus £1.86 in England.

    81.7%
    Breast screening and older-adult control outpace benchmarks.

    Breast screening is 81.7% (England 69.9%), while frail diabetes HbA1c control reaches 84.2% (England 81.9%) and 80+ BP control rose +4.7% (England +2.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 18 to 64 comprise 67.3% alongside 8,645 older adults

    Across 54,360 registered patients, 67.3% (36,572) are aged 18-64, compared with 71.4% in Brighton and Hove (LAD), 60.5% in NHS Sussex Integrated Care Board, and 62.7% in England. Patients aged 65 and over comprise 15.9% (8,645), compared with 14.0% in Brighton and Hove (LAD), 21.9% in NHS Sussex Integrated Care Board, and 17.9% in England. Census usual residents in associated areas are 85.6% White (Brighton and Hove (LAD) 85.4%, NHS Sussex Integrated Care Board 91.0%, England 81.1%), leaving a 14.4% ethnic minority share.

    Age profile

    0–1716.8%
    18–6467.3%
    65+15.9%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White85.6%
    Mixed5.1%
    Asian4.7%
    Other2.5%
    Black2.0%

    Older people · falls rows are Brighton and Hove (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Brighton and Hove LA)2,7022,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.9%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Brighton and Hove LA)1,4859819552024/25
    Falls deaths, all ages, per 100,000 (Brighton and Hove LA)19.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 7.8%, below national and borough levels

    The Core20 cohort (IMD quintile 1) comprises 7.8% of registered patients at PCN level, below England (21.0%) by 13.3 percentage points, below Brighton and Hove (LAD) (17.6%) by 9.8 percentage points, and below NHS Sussex Integrated Care Board (9.2%) by 1.4 percentage points. Core20 reflects residence in the most deprived national areas and is not a local performance target.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Stanford16.4% · 2,720 patients
    Preston Park7.4% · 941 patients
    Beaconsfield1.2% · 168 patients
    Warmdene0.0% · 0 patients
    Haven0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    588

    SMI register

    1.03% recorded prevalence

    289

    Learning disability register

    0.51% recorded prevalence

    23

    Care homes, 578 beds

    In the PCN catchment

    8.2%

    Provide unpaid care

    Brighton and Hove (LAD), Census 2021

    Recorded prevalence is 1.0% for severe mental illness (588 patients; England 1.0%) and 0.5% for learning disability (289 patients; England 0.6%). The PCN catchment contains 23 care homes with 578 beds. Crude register prevalence does not establish unmet need or coding quality, and care home bed capacity does not establish occupancy or registered resident numbers.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 72.3% (England 83.4%; Brighton and Hove 77.2%), with Beaconsfield Medical Practice at 60.9%, while BMI recording was 72.6% (England 82.1%). Lagging published checks is consistent with physical health review gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,358

    Hypertension register

    +8.03%

    Register growth, 3 yrs

    Brighton and Hove (LAD) +7.27% · England +5.60%

    +0.89pp

    BP control, under 80

    ≤140/90 · +3.58pp aged 80+

    +1,170

    More patients by 2030

    Forecast 7,528 (13.02%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 11.2% (6,358 patients), above Brighton and Hove (10.5%) but below NHS Sussex Integrated Care Board (16.3%) and England (15.2%), though the register grew +8.0% over 2023 to 2025 (England +5.6%). For patients under 80, blood pressure control to <= 140/90 mmHg is 65.8% (England 67.8%), while in patients aged 80 and over control reaches 79.1% (England 81.2%), rising +4.7% over 2023 to 2025 (England +2.2%). Crude prevalence may reflect a younger list (67.3% aged 18-64), and matching observation bases cannot be confirmed. Lower control rates in patients under 80 compared with England indicate an opportunity to expand structured blood pressure reviews across primary care.

    Lipids and statins

    Lipid-lowering therapy reaches 56.6% in patients with QRISK >= 20% (England 63.6%), 59.1% in CKD (England 70.3%), and 78.8% in diabetes with CVD (England 84.4%). Trailing national coverage across all three cohorts indicates an urgent opportunity to prioritise recall audits for high-risk patients needing lipid-lowering therapy.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202656,030£2.70£2.42£1.86£151,281
    Cardiovascular (all), 202580,642£3.32£3.32£3.33£267,731

    In 2026, lipid-modifying drugs cost £2.70 per item across 56,030 items, compared with £1.86 in England and £2.42 in NHS Sussex Integrated Care Board, spending £47,065 more than at England's unit cost. Higher unit costs than England indicate an opportunity to review local formulary choices and prescribing spend across member practices, noting unit cost is not efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.94%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.51%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual review coverage fell 2.9% over 2023 to 2025 (England +4.4%) to 56.0% (England 65.7%; Brighton and Hove 60.1%), leaving about 1,400 unreviewed of 3,259 registered patients. COPD reviews reached 68.0% (England 76.4%), with 682 patients on the register. Prescribing of asthma management items for ages 5-19 was 959 rate per 1,000 (England 1,488 rate). Trailing reviews may reflect unverified routine recall shortfalls.

    Cancer register and children's immunisation

    The cancer register records 2,100 patients (3.7% prevalence vs England 3.8%). In childhood immunisations, 6-in-1 coverage at 12 months is 88.0% (NHS Sussex ICB 92.9%; England 91.0%), falling 7 pp below the 95.0% target. At age 5, MMR dose 2 is 89.6%, trailing MMR dose 1 (94.8%) by 5.2 pp, which could reflect unverified recall delays before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.0%

    England 91.0%

    6-in-1 complete primary course at 24 months93.1%

    England 92.2%

    MMR dose 1 at 24 months92.0%

    England 88.3%

    MMR dose 2 at age 589.6%

    England 82.8%

    4-in-1 pre-school booster at age 588.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB, 58.5% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (4,799 of 8,209 staged cases), rising 5 pp since 2013 and above England (55.3%), but below the 75.0% national ambition by 16.5 pp (about 1,360 extra early-stage cases needed). Staged cancers were 64.3% of registrations (England 67.0%). Cancer register prevalence is 3.7% (2,100 patients), rising +13.4% over 2023 to 2025 (England +9.0%). Breast screening reached 81.7% (England 69.9%). Cervical screening is 68.6% (England 66.8%), but fell 2.3% over 2023 to 2025 (England -1.0%) and is 57.4% at Stanford Medical Centre.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, University Hospitals Sussex NHS Foundation Trust met the 62-day cancer standard for 65.2% of pathways, trailing East Sussex Healthcare NHS Trust (67.0%), Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%), and below the 85.0% standard by 19.8 pp. Its 28-day faster diagnosis standard was 74.0% (England 79.3%; 75.0% standard). For 6+ week diagnostic waits, MRI was 5.6% and CT was 8.6% (England 21.4% and 9.9%). These figures reflect acute provider waiting times and do not measure PCN referral performance.

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityBrighton and Hove residentsSurrey and Sussex ICB
    Care contacts23,615309,615
    Referrals5,59066,930
    Patients with a contact7,35085,660

    Community services (residents of Brighton and Hove), Jun 2026 (provisional). In Jun 2026 (provisional), community health service contacts for Brighton and Hove residents totalled 23,615, of which 14,325 (60.7%) were with adults aged 65 and over. These figures describe activity across all borough residents rather than PCN-specific care, illustrating older-adult demand across community health services.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice telephone access spans 51.8 pp and vaccination achievement spans 74.6 pp

    In 2025/26, QOF clinical-domain achievement was 99.2% at Beaconsfield Medical Practice (England 97.1%). In the vaccination and immunisation domain, achievement spanned 74.6 pp, from 17.2% at Stanford Medical Centre (personalised care adjustment rate 7.4%) to 91.7% at Warmdene Surgery, compared with 55.2% across England.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    The Haven Practice1150.091.4%82.9%90.9%
    Warmdene Surgery1270.076.8%81.1%90.2%
    Beaconsfield991.259.4%70.4%86.8%
    Stanford9516.471.0%63.7%82.3%
    Preston Park1157.439.6%70.1%73.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBrighton and Hove (LAD)AssetPCNBrighton and Hove (LAD)
    Care homes (catchment)23 (578 beds)n/aSchools (catchment)70n/a
    Children's centres614Places of worship40113
    Libraries413Homelessness support (VCS)0no data
    Primary schools (LA maintained)1835Primary academies27
    Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and COPD review recall

    Asthma review coverage is 56.0% (England 65.7%; Brighton and Hove 60.1%), falling 2.9% over 2023 to 2025 (England +4.4%), leaving about 1,400 of 3,259 patients unreviewed; COPD reviews reach 68.0% (England 76.4%) across 682 patients. For discussion: run combined asthma and COPD recall with flexible slots and inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    High-risk lipid recall and formulary review

    Lipid-lowering therapy trails England in CKD (59.1% vs 70.3%), QRISK >= 20% (56.6% vs 63.6%), and CVD diabetes (78.8% vs 84.4%); 56,030 lipid-modifying items cost £2.70 each vs £1.86 in England (£47,065 more). For discussion: deploy pharmacist-led recall for untreated high-risk cohorts alongside a practice formulary review. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    SMI health checks and immunisation recall

    Across 588 SMI patients, BP checks reach 72.3% (England 83.4%) and 60.9% at Beaconsfield Medical Practice; 12-month 6-in-1 coverage is 88.0% (England 91.0%) and age-5 MMR2 is 89.6% (5.2 pp below MMR1 at 94.8%). For discussion: combine SMI health checks with targeted recall for overdue 6-in-1 and MMR2 doses. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Working age and frailty access (p2)Aged 18-64Neighbourhood health frameworkPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure review protocol (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation recall (p6)6-in-1 coverage at 12 months10YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice access and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma and COPD review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD patients with a review in the last 12 monthsCore20PLUS5 respiratoryPCN
    Option 2 · High-risk lipid recall and formulary review (p12)CKD patients treated with lipid lowering therapy · Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs)NHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Option 3 · SMI health checks and immunisation recall (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15